Amsler Grid Not Sensitive Enough for Diagnosing Neovascular AMD
MONDAY, Feb. 27, 2023 -- The Amsler grid has a sensitivity of 67 percent for diagnosing neovascular age-related macular degeneration (AMD) compared with healthy controls, according to a systematic review and meta-analysis published online Feb. 16 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Pharmaceuticals